Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins

Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins

0:00

Anthony Bavry, The Cleveland ClinIc, OH American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 821-5 All cause mortality can be reduced by 25 per cent if

Anthony Bavry

Anthony Bavry, The Cleveland ClinIc, OHAmerican College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta.Abstract Number: 821-5All cause mortality can be reduced by 25 per cent if you give your acute coronary syndrome patients early aggressive statin therapy in addition to the usual medications. That’s according to a meta-analysis of smaller studies comparing early aggressive stating therapy with lower doses of statins. Sarah Maxwell spoke with Anthony Bavry during the American College of Cardiology session in Atlanta.

Related Episodes

Remove Thrombus Before Primary Angioplasty!

Remove Thrombus Before Primary Angioplasty!

Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,

Heart Failure Drug Prevents Renal Damage?

Heart Failure Drug Prevents Renal Damage?

Barry Massie Barry Massie, San Francisco VA Medical Center COMMENT: Aaron Kugelmass, Henry Ford Hospital, Detroit The adenosine A1-receptor antagonist rolofylline appears to prevent renal impairment a

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Peter Tyrer REFERENCE: Lancet 371:57 January 5, 2008 PETER TYRER, Imperial College, W6 8RP London A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients